results good this is going to fly, page-12

I must stress for those not in the know they are not just targeting the market of liver cancer.

PI88 is 2/3rd of the way through phase 2 trials on Melanoma

PI88 is 2/3rd of the way through phase 2 trials on lung cancer results expected before June

A quarter of the way through phase 2 trials for prostate cancer and multiple myeloma.

As well as being in preclininical and discovery on 6 other cancers

The total market for these is well in excess of 30 bill a year and growing fast

http://www.progen.com.au/?page=pitrials.html